India bans exports of possible coronavirus treatment hydroxychloroquine
The move comes a day after India, the world's second-largest country, went into lockdown
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.
India banned the export of hydroxychloroquine, a drug that is being tested as a coronavirus treatment, after the U.S. Food and Drug Administration lifted its ban on importing the drug from India this week.
The move raises concerns that there could be a possible shortage of the drug. The news comes a day after India, the world's second-largest country, went into lockdown to reduce spread of the virus. India has confirmed more than 560 cases, according to Johns Hopkins University's coronavirus map.
WHAT ARE HYDROXYCHLOROQUINE AND CHLOROQUINE?
New York began trials of hydroxychloroquine and chloroquine, often used in the treatment of malaria, on Tuesday.
Medical staff shows packets of a Nivaquine, tablets containing chloroquine and Plaqueril, tablets containing hydroxychloroquine, drugs that has shown signs of effectiveness against coronavirus. (Photo by GERARD JULIEN/AFP via Getty Images)
Drugmakers Bayer, Mylan and Novartis make versions of hydroxychloroquine and have separately committed to donating tens of millions of tablets to efforts to cure the virus.
Trump has touted the possibility of using the drugs as widespread treatment for the virus.